Avacta Group (LON:AVCT) Shares Cross Below 200 Day Moving Average - Here's Why

Shares of Avacta Group Plc (LON:AVCT - Get Free Report) crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 40.26 ($0.55) and traded as low as GBX 31.31 ($0.43). Avacta Group shares last traded at GBX 32.44 ($0.45), with a volume of 2,904,912 shares traded.

Avacta Group Trading Up 4.7%

The firm has a market capitalization of £121.34 million, a price-to-earnings ratio of -4.11 and a beta of 1.12. The company has a quick ratio of 4.96, a current ratio of 1.29 and a debt-to-equity ratio of 52.53. The business's 50-day simple moving average is GBX 33.06 and its two-hundred day simple moving average is GBX 40.02.

Avacta Group (LON:AVCT - Get Free Report) last issued its quarterly earnings results on Friday, June 6th. The biotechnology company reported GBX (8.54) (($0.12)) earnings per share (EPS) for the quarter. Avacta Group had a negative return on equity of 74.00% and a negative net margin of 114.45%. Equities analysts forecast that Avacta Group Plc will post -9.9011833 earnings per share for the current year.

About Avacta Group

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics. The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US. Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).